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At the present time, the incidence of malignant melanoma is rising
steadily in all parts of the world for which accurate data are available. For
example, in Scotland between 1979 and 1989, the incidence of
melanoma rose by 80%, or 7.4% per annum [1]. The present doubling
time for the incidence of melanoma for men in Scotland is 8 years and for
women 13.5 years. Similar steep rates of increase are observed in other
European countries such as Denmark [2] and in other parts of the world as
well, including New Zealand. Until recently, 5-year survival figures for
malignant melanoma were approximately 50%. If, however, patients are
stratified according to Clark levels or Breslow thickness, striking
differences in survival are immediately obvious. For example, in the
Scottish series of 1660 patients registered between 1979 and 1984, for
whom 5-year follow-up figures are now available, patients with tumors
less than 1.5mm in thickness have a 5-year disease-free survival figure
of 93%; those with tumors 1.5–3.49mm thick have a 5-year survival
prospect of 73%; and those with tumors thicker than 3.5mm have a
5-year survival of less than 48% [1]. These figures suggest that if a higher
proportion of patients can be educated to recognize early melanoma and
present for treatment of malignant melanoma that is at a thin, early growth
stage, deaths from melanoma will at least stabilize and not increase at a
rate commensurate with the increasing incidence. The other approach to
controlling deaths from melanoma is of course longer term public
education exercises aimed at reducing the actual incidence of melanoma.
Early Exercises in Melanoma Education The earliest exercises in public
education about malignant melanoma took place in Queensland,
Australia, in the 1960s. Prior to that time little information was available
for the entire State of Queensland, but data collected between 1960 and
1980 showed that in Queensland the annual incidence rose from 15.1/
100,000 in 1966 to 25/100,000 in 1977 and 31.4/100,000 in 1982 [3,4].
In 1982, if non-melanoma skin cancer is excluded, malignant melanoma
comprised 10% of all malignancies recorded in the state of Queensland.
This, taken together with the fact that worldwide a high proportion of
patients with melanoma are relatively young and that the average age
worldwide of patients with melanoma is mid-50s, is a clear indication of
the public health problem of melanoma in countries with high solar
intensity. Studies from Queensland show that while public education was
in progress, the mean tumor thickness fell but incidence of and mortality
from melanoma continued to rise.
Current Approaches to Public Education About Early Melanoma
Approaches to public education about features of early melanoma require
careful preparation. Public education campaigns need to be widely
disseminated to inform the general public of the features that are more
commonly found in malignant melanoma at an early growth stage than in
other pigmented but benign possible simulators of malignant melanoma
(e.g., seborrheic keratoses). Depending on the average clinical appear-
ance when melanomas are identified in different countries, different
examples of malignant melanomas will be required for use as illustrations
for public education. For example, in a country where the average
malignant melanoma excised is still a relatively advanced lesion with a
significant vertical growth component, the illustrations shown will need to
be more advanced than those in a country in which some education has
already occurred and the average melanoma excised is much smaller,
with little if any vertical growth component. For this reason, in some
countries such as Scotland, the approach has been to carry out a careful
survey of a large number of melanomas excised in the years preceding
public education activities, using the thinnest examples in this sample to
illustrate the features to be recognized [5].
Preparatory Work Necessary for Public Education Campaigns Public
education campaigns should by definition attract a high proportion of
people with clinically suspect lesions. However, it is well recognized that
even in the hands of experts, clinical diagnostic accuracy in the
recognition of malignant melanoma by no means approaches 100%.
Recent studies have suggested that an average of approximately 50%
clinical accuracy in pre-biopsy recognition of early melanoma can be
achieved and that in the hands of experts, this can increase to between 80
and 90% [6].
Some workers have both in the past and at present made use of skin-
surface microscopy or the dermatoscope in an effort to increase pre-
operative diagnostic accuracy. In an early study, MacKie reported 85%
pre-operative diagnostic accuracy with such equipment [7], and more
recently, similar rates of pre-operative diagnostic accuracy have been
reported from the Austrian group [8]; however, use of even the simplified
dermatoscope requires some experience, and for the foreseeable future,
public education campaigns will be based on simple naked-eye
recognition of the salient features of early melanoma. At present, trials
are under way in a number of centers investigating the potential of
computerized image analysis, both in recognition of early melanoma and
in subsequent surveillance of suspect lesions.
Once the clinical features of early melanoma to be illustrated in public
education material have been determined, it is necessary to organize the
appropriate referral arrangements for patients who are concerned about
possible early malignant melanoma. In the United States, the approach
has been to use skin cancer fairs, with dermatologists or other experts
available to examine self-referred individuals who have attended because
of the publicity on television and local radio or in local newspapers. At
these fairs, skin examination is offered and may be confined to the site
requested by the patient or may be a total-body skin examination. At such
fairs, advice is given on appropriate further action to be taken by the
patient, but excision biopsies and follow-up are not available because of
ethical considerations with regard to patient referral. Patients with
worrisome lesions are advised to consult their own dermatologist without
delay, and those without a dermatologist are given a list of appropriate
local practitioners. This approach to screening for possible early treatable
melanoma clearly depends on appropriate action by the member of the
public concerned, in first attending for a free examination and in then
taking further action. Follow-up of attendees at these skin cancer fairs
thought to have possible early melanoma has shown that by no means all
those counseled to seek further advice without delay do so [9,10]. Thus,
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the organizational details of these cancer fairs make clinical audit
impractical, other than the immediate counting of number of attendees
and their characteristics.
The approach to public education about melanoma in the United
Kingdom has been the wide distribution of appropriate leaflets, videos,
and posters illustrating the features of early melanoma as seen at present
in the United Kingdom and encouraging referral first to the family doctor
[11]. The family doctor then makes the decision as to the need for referral
to the specialist, and if this is considered necessary, makes use in many
centers of specially established pigmented-lesion clinics. These clinics
work on a ‘‘no waiting list’’ basis, and surgical facilities are available for
either biopsy or excision of small lesions. In the great majority, however,
self-referral without prior consultation with the general practitioner is
discouraged. Thus, family physician education has been undertaken with
a considerable degree of success.
An approach in The Netherlands over the past 2 years has been that of
a caravan established on holiday beaches offering advice to those
concerned about growing or changing pigmented lesions on the skin. This
approach has encouraged examination only of the area chosen by the
patient, and has then encouraged consultation with the patient’s own
family doctor. This appears to have stimulated interest, and a large
number of people consult these caravans, but as with the U.S. skin cancer
fairs, follow-up is difficult.
Assessment of Public Education The four examples cited above are all
illustrative of different approaches to public education aimed at
encouraging earlier treatment of thinner melanomas and thus reducing
melanoma-associated mortality. In the field of cancer education and
screening for occult early malignancy, audit of the effects of these
activities is vital. Public education requires a budget, and some of the
exercises planned are expensive. It is therefore highly desirable to have
some concept of the relative costs per patient identified, similar to that
produced by those involved in breast and cervical cancer screening,
although accurate costing and inclusion of appropriate overheads are
extremely difficult. Much more important, however, is the need to
document the medical success of these exercises. It cannot be assumed
that all such exercises are positively beneficial, and audit measures on
such studies should include measures designed to detect positive and
negative effects.
Audit Measures
1. Pre-circulation developmental testing of the literature, posters, and
other material to be used in public education – does it adequately
inform and encourage action rather than instill fear and denial?
2. When the campaign is launched, how comprehensive was the take-
up of material from press conferences? How many newspapers,
radio, and television stations ran a piece on the information?
3. How widely distributed were the posters and leaflets?
4. How many people attended the designated referral center or walk-in
clinic?
5. What had prompted their attendance? Television, leaflet, poster, or
other?
6. Is the population attending the desired target population (e.g., adults
with phenotypic risk factors for melanoma – fair hair, blue eyes, pale
skin?). Some recent campaigns have had problems with a large
attendance of non-whites with dark skin color on the basis that the
clinic was for those with pigmented skin, not those with pigmented
lesions. Similarly, a different campaign that did not clearly indicate the
age range at risk resulted in attendance of large numbers of pubertal
children whose parents were concerned about the appearance of
totally banal nevi.
7. What is the proportion of men and women in different age groups
attending relative to the local population? Most studies find that
younger women are the best attenders and are relatively over-
represented and that older men are difficult to target and therefore
are under-represented.
8. How many melanomas are identified and treated in these referral
centers or as a result of attendance at them as a result of the
campaign?
9. What are the characteristics of the patients with these lesions and of
the lesions themselves? For example, is it easier to encourage men or
women to come forward, and are lesions on the limbs over-
represented by comparison with lesions on the trunk? Are superficial
spreading melanomas easier for the general public to recognize than
nodular lesions?
10. What is the ratio of melanomas diagnosed in these centers to non-
melanomas seen? This will give some indication of the specificity of
the information disseminated and the unnecessary work generated.
The figures quoted for the U.S. experience are one melanoma for
250 patients seen and in the United Kingdom, one melanoma for
every 25 patients referred to a pigmented-lesion clinic.
11. Over time, is the trend in melanomas diagnosed in the target area in
favor of thinner melanomas? Clearly, this requires knowledge of the
trends with regard to tumor thickness for some years prior to
educational intervention and will require a campaign to continue for
several years.
A highly desirable but difficult to obtain additional item is information
on melanoma thickness changes in a geographically adjacent but non-
educated group (non-intervention group) over the same time period to
control for events other than the planned educational intervention being
responsible for tumor thickness changes. The practical problem with this
is that if educational publicity is effective, and television, radio, and
newspapers all carry information, it will be disseminated over a wide
area. If the aim is to compare intervention and non-intervention areas,
then leaflets delivered to individual households is a possible alternative
strategy.
If Breslow thicknesses are to be measured over time, it will
be necessary to have a panel of pathologists available who
are experienced in the study of melanocytic lesions and whose accuracy
is not in doubt. Ideally, a team of four or five pathologists should establish
their consistency, both internally over time and externally with each
other, with regard to reporting the salient features of malignant
melanomas, and then be used to review all material excised from people
whose lesions require measurement to assess the effect of the educational
intervention. An alternative method is to rely on reports sent in by
individual reporting pathologists in the various centers, but even if this is
regarded as acceptable, some sampling of reliability and assessment by a
panel of pathologists is highly desirable.
It is possible that a changing trend in Breslow thickness over time
could be due to features other than the educational activity planned.
Features known to be associated with thin tumors include female gender,
lesions on the limbs, lentigo maligna melanomas, and a younger age at
excision. It is therefore desirable to control for simultaneous changes in
any or all of these features and to have information on these features in a
population prior to and during education. Appropriate statistical methods
will be needed to control for these possibly significant variables.
The desired end point of this type of educational exercise is a
reduction in melanoma-associated mortality. Studies on large populations
of melanomas suggest that the great bulk of recurrences take place within
2–3 years of excision of the primary tumor, but in the case of thinner
tumors, a small but growing group of patients have recurrences as long as
7–10 years after excision of primary tumors. For these reasons, mortality
will have to be followed over several years before any changes related to
educational intervention can be expected and their significance with
regard to the educational strategies assessed. Audit of the Scottish
educational campaign shows an encouraging fall in the absolute number
of melanomas greater than or equal to 3.5mm thick and also of
melanoma-related mortality in women in the entire country but not in
men [12]. As with the other measures of efficacy, information on mortality
trends prior to educational intervention is highly desirable. At the present
time, for example, in many parts of the world, although the incidence
of melanoma is rising at a rate of approximately 7–10%/year (see
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Approaches to Control of Malignant Melanoma), the mortality from
melanoma is rising much less rapidly, even in parts of the world where no
planned educational intervention is in progress. The reasons for this are
not well established but may be due to a general trend toward detection of
smaller, thinner tumors. It is therefore important to have pre-educational
information on this fact against which to measure any trends or any
changes in trends in mortality associated with melanoma following
education.
In the 1–2 years after effective public education, greater melanoma
awareness may result in prevalent as well as newly incident melanomas
receiving treatment. This will cause a transient rise, followed by a dip in
the crude incidence rate for the geographic area concerned.
Auditing of Non-Desirable Effects of Education It has already been stated
that it cannot be assumed that all educational intervention is beneficial.
Examples of inappropriate education and a demand for services from a
population to a medical profession that is unprepared for that demand
would include a steep rise in waiting time for surgical excision of a
suspect lesion, a delay in reporting of pathology, the non-availability of
appropriately trained pathologists, and a very steep rise in the workload of
those seeing and excising suspect pigmented lesions that were not
melanomas. This last would in fact greatly increase the waiting time for a
patient with a true melanoma to receive appropriate treatment and is an
example of a situation in which educational intervention could create an
adverse situation rather than a null situation or an improvement in that
which preceded it.
For these reasons, it is highly desirable to audit the workload
associated with patients stimulated to come forward as a result of
educational material but who do not have melanoma. Many of these will
have totally innocuous, benign pigmented lesions, such as seborrhoeic
keratoses, and if they are seen at an appropriate referral center that is
staffed by those with experience in examination of pigmented lesions, this
should not be too time-consuming. More time-consuming is the group of
patients with nevi that may be dysplastic or otherwise clinically atypical
and do require surgical excision and confirmation of pathology. These
patients clearly generate a minor surgery and pathology workload, and the
volume of this workload relative to the background volume related to
such lesions prior to education must be considered. In a country with a
health care system based mainly on the private sector, an increase in non-
melanoma referrals stimulated by such activities will not cause major
problems, but in a country with a nationalized system where there are a
limited number of dermatologists and surgeons, a rise in this proportion
could cause major problems, with long waiting lists. The situation for a
patient with an early melanoma could in fact be worsened by public
education if large numbers of inappropriate referrals cause delays in the
system.
CONCLUSIONS
The rapidly increasing numbers of patients with melanoma and the added
concern that this situation will deteriorate further as a result of ozone
depletion are clear indications for the need to try to reduce melanoma-
related deaths. At present, there are no campaigns that have reported
success in reducing the actual incidence of melanoma by encouraging the
public to change their behavior with regard to sun exposure or by any
other approach. Even if the exercises described above to reduce
melanoma mortality are successful by encouraging treatment of thinner
lesions, a higher proportion of surgical and dermatologic time and
resources will still be utilized in treating the larger numbers of melanomas
anticipated; however, it must still be proved without doubt that earlier
recognition and treatment do in fact lead to reduced mortality. In the field
of breast cancer education, earlier diagnosis has not in all studies led to
the anticipated reduction in mortality. One reason advocated for this is
the problem of lead-time bias, which is based on the assumption that from
the outset breast cancer is a systemic disease and that earlier diagnosis
increases the time during which the patient is aware of her disease but
does nothing to change the eventual time span from start of growth of the
malignancy to death. No similar studies have been carried out on
melanoma, and early-diagnosis campaigns depend on the assumption that
melanoma can be diagnosed and treated before it disseminates.
Information on the numbers of patients attending designated self-referral
or advice centers, or data suggesting a falling median primary tumor
thickness are encouraging, but are not an end point in itself.
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